Free light chain testing in follow-up of multiple myeloma

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 8, 2006, Pages 1044-1046

  Van Gysel, Marjan ^a   Mariën, Godelieve ^a   Verhoef, Gregor ^a   Delforge, Michel ^a   Bossuyt, Xavier ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Light chain; Monoclonal protein; Multiple myeloma

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MELPHALAN; PREDNISOLONE; THALIDOMIDE; VINCRISTINE;

CAPILLARY ZONE ELECTROPHORESIS; CHEMOTHERAPY; CONCENTRATION (PARAMETERS); ELECTROPHORESIS; FOLLOW UP; HUMAN; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; LETTER; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TIME SERIES ANALYSIS;

BLOOD PROTEINS; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULINS; MULTIPLE MYELOMA;

EID: 33746591765     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.188     Document Type: Letter

References (18)

1. Keren DF, Alexanian R, Goeken JA, Gorevic PD, Kyle RA, Tomar RH. Guidelines for clinical and laboratory evaluation patients with monoclonal gammopathies. Arch Pathol Lab Med 1999;123:106-7.
2. Sirohi B, Powles R. Multiple myeloma. Lancet 2004;363:875-87.
3. Bossuyt X, Schiettekatte G, Bogaerts A, Blanckaert N. Serum protein electrophoresis by CZE 2000 clinical capillary electrophoresis system. Clin Chem 1998;44:749-59.
4. Mariën G, Oris E, Bradwell AR, Blanckaert N, Bossuyt X. Detection of monoclonal proteins in sera by capillary electrophoresis and free light chain measurements. Clin Chem 2002;48:1600-1.
5. Bradwell AR, Carr-Smith H, Mead GP, Tang LX, Showell PJ, Drayson MT, et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001;47:673-80.
6. Bradwell AR Serum free light chain measurements move to center stage. Clin Chem 2005;51:805-7.
7. Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, et al. Serum reference intervals and diagnostic ranges for free κ and free λ immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 2002;48:1437-44.
8. Tate JR, Devinder G, Cobcroft R, Hickman P. Practical considerations for the measurement of free light chains in serum. Clin Chem 2003;49:1252-7.
9. Abraham RS, Katzmann JA, Clark RJ, Bradwell AR, Kyle RA, Gertz MA. Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis. Am J Clin Pathol 2003;119:274-8.
10. Bradwell AR, Carr-Smith H, Mead GP, Harvey TC, Drayson MT. Serum test for the assessment of patients with Bence Jones myeloma. Lancet 2003;361:489-91.
11. Drayson M, Tang LX, Drew R, Mead GP, Carr-Smith H, Bradwell AR. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood 2001;97:2900-2.
12. Katzmann JA, Abraham RS, Dispenzieri A, Lust JA, Kyle RA. Diagnostic performance of quantitative κ and λ free light chain assays in clinical practice. Clin Chem 2005;51:878-81.
13. Lachmann HJ, Gallimore R, Gillmore JD, Carr-Smith HD, Bradwell AR, Pepys MB, et al. Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. Br J Haematol 2003;122:78-84.
14. Matsuda M, Yamada T, Gono T, Shimojima Y, Ishii W, Fushimi T, et al. Serum levels of free light chain before and after chemotherapy in primary systemic AL amyloidosis. Intern Med 2005;44:428-33.
15. Mead GP, Carr-Smith HD, Drayson MT, Bradwell AR. Detection of Bence Jones myeloma and monitoring of myeloma chemotherapy using immunoassays specific for free immunoglobulin light chains. Clin Lab 2003;49:25-7.
16. Kang S, Suh J, Lee H, Yoon H, Lee W. Clinical usefulness of free light chain concentration as tumor marker in multiple myeloma. Ann Hematol 2005;84:588-93.
17. Mead GP, Carr-Smith HD, Drayson MT, Morgan GJ, Child JA, Bradwell AR. Serum free light chains for monitoring multiple myeloma. Br J Haematol 2004;126:348-54.
18. Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Cancer 1975;36:842-54.